SynAgile Corporation Announces Closing of $10.4M of Financing

August 24th, 2017

SynAgile Corporation, a privately held pharmaceutical company that develops and commercializes drug delivery systems using its proprietary OraFuse® technology platform, today announced the closing of a $10.4 million round of equity investment.

Read More

83-year-old invents Parkinson's "Retainer" to deliver Oral Levodopa

March 2nd, 2017

“I would love to see the device widely used by people, while I’m still alive,” says Dr Adam Heller. The 83-year-old research professor at the University of Texas, US, who has more than 260 US patents...

Read More

SynAgile Corporation Announces Positive Phase 2A Results

October 8th, 2015

SynAgile Corporation, a privately held pharmaceutical company that develops and commercializes drug delivery systems using its proprietary OraFuse® intraoral technology platform, today announced positive results from a proof-of-concept...

Read More

SynAgile Study Selected for Late Breaking Abstract for MDS 2016

May 27th, 2016

SynAgile's Proof-of-Concept Study was selected as a Late Breaking Abstract for the 2016 Movement Disorders Symposium. View the poster by clicking below

Read More